Sponsor:
University of Southern California
Code:
NCT07332312
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Interventions
Discussion
Discussion
Educational Intervention
Electronic Health Record Review
Interview
Brief summary:
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT07332312
Start date
Apr 17, 2026
Status verified date
May, 2026
Completion date
Nov 13, 2028
Anticipated
Primary completion date
Nov 13, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Enrollment
71 participants
Anticipated
Allocation
Non randomized
Intervention Model
Sequential
Primary purpose
Supportive Care
Arms
other: Objective 1 group I (CAB)
other: Objective 1 group II (focus group)
other: Objective 1 group III (KII)
experimental: Objective 2 (CFPN program)
Interventions
Discussion
Discussion
Educational Intervention
Electronic Health Record Review
Interview
Interview
Patient Navigation
Survey Administration
Tailored Intervention
Primary outcome measure
Locations
Toiyabe Indian Health Project
Recruiting
Bishop, California, United States, 93514
Contacts
Principal Investigator:
Tina Cassar
USC / Norris Comprehensive Cancer Center
Recruiting
Los Angeles, California, United States, 90033
Contacts
Principal Investigator:
Claradina Soto
Sponsor
University of Southern California
Last update posted
May 11, 2026
Last verified
May, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Southern California on 2026-05-11.